Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.
Frequently asked questions
What sector does Cannabis Bioscience International Holdings Inc. (CBIH) operate in?
Cannabis Bioscience International Holdings Inc. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Cannabis Bioscience International Holdings Inc. (CBIH) current stock price?
As of the latest data, Cannabis Bioscience International Holdings Inc. stock price is $0.00, with a previous close of $0.00. Cannabis Bioscience International Holdings Inc. lost -$0.00 in the last trading session, representing a -50% loss.
What is Cannabis Bioscience International Holdings Inc. (CBIH) current market capitalization?
Cannabis Bioscience International Holdings Inc. market cap is approximately 1.16 million.
Does Cannabis Bioscience International Holdings Inc. (CBIH) pay dividends?
No. Cannabis Bioscience International Holdings Inc. does not pay a dividend.
What is Cannabis Bioscience International Holdings Inc. (CBIH) beta (volatility) score?
Cannabis Bioscience International Holdings Inc. has a beta of 0.942, meaning its volatility is roughly in line with the market.
